Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MPI Research Executive to Serve as ACT President | Contract Pharma

What are you searching for?

Sign in
Breaking News

MPI Research Executive to Serve as ACT President

Serota brings 34 years of toxicology expertise

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

David Serota, Ph.D., DABT, MPI Research’s senior vice president of drug safety development and senior principal study director, will serve as the 2012 American College of Toxicology (ACT) president. Dr. Serota has been a member of ACT since 1981 and has served on the membership committee, served as councilor, vice president, and president-elect. During his role as vice president he chaired the awards committee, and most recently chaired the program committee as president-elect.

Dr. Serota has held numerous scientific and leadership positions for the past 34 years. Before joining MPI Research in 1997, he served as director of laboratory operations and senior staff scientist at Hazleton Laboratories America (now Covance), and director of toxicology at Southern Research Institute. He has conducted and reported more than 1,000 toxicology studies during his career in the preclinical research industry.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics